Iron chelator induces THP-1 cell differentiation potentially by modulating intracellular glutathione levels

Free Radical Biology and Medicine

Volumn 40, Issue 9, 2006, Pages 1502-1512

  Seo, Geom Seog ^a   Lee, Sung Hee ^b   Choi, Suck Chei ^a   Choi, Eun Young ^c,d   Oh, Hyun Mee ^c,d   Choi, Eun Ju ^c,d   Park, Do Sim ^a   Kim, Sang Wook ^e   Kim, Tae Hyeon ^a   Nah, Yong Ho ^a   Kim, Soonhag ^f   Kim, Sang Hyun ^g   You, Sun Hae ^h   Jun, Chang Duk ^c,d  

^a Wonkwang University School of Medicine   (South Korea)

^b Wonkwang University   (South Korea)

^c Kyungpook National University School of Medicine   (South Korea)

^d Gwangju Institute of Science and Technology (GIST)   (South Korea)

^e Chonbuk National University Medical School   (South Korea)

^f Korea National Institute of Health   (South Korea)

^g Kyungpook National University   (South Korea)

^h Weol myung Middle School Kunsan   (South Korea)

Author keywords

Class A scavenger receptor; Deferoxamine; Extracellular signal regulated kinase; Free radical; Glutathione; Iron chelator; p38; Phagocytic activity

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ACETYLCYSTEINE; DEFEROXAMINE; FERRIC CITRATE; GLUTATHIONE; IRON CHELATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; SCAVENGER RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MACROPHAGE; OXIDATIVE STRESS; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

BLOTTING, WESTERN; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE, TUMOR; DEFEROXAMINE; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; GLUTATHIONE; HUMANS; IRON CHELATING AGENTS; LEUKOCYTES, MONONUCLEAR; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHAGOCYTOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCAVENGER RECEPTORS, CLASS A; TRANSFECTION;

EID: 33646073995     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.12.020     Document Type: Article

References (44)

1. Marx J.J. Iron and infection: competition between host and microbes for a precious element. Best Pract. Res. Clin. Haematol. 15 (2002) 411-426
2. Weiss G., Werner-Felmayer G., Werner E.R., Grunewald K., Wachter H., and Hentze M.W. Iron regulates nitric oxide synthase activity by controlling nuclear transcription. J. Exp. Med. 180 (1994) 969-976
3. Andrews F.J., Morris C.J., Kondratowicz G., and Blake D.R. Effect of iron chelation on inflammatory joint disease. Ann. Rheum. Dis. 46 (1987) 327-333
4. Bowern N., Ramshaw I.A., Clark I.A., and Doherty P.C. Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent. J. Exp. Med. 160 (1984) 1532-1543
5. Dlaska M., and Weiss G. Central role of transcription factor NF-IL6 for cytokine and iron-mediated regulation of murine inducible nitric oxide synthase expression. J. Immunol. 162 (1999) 6171-6177
6. O'Brien-Ladner A.R., Blumer B.M., and Wesselius L.J. Differential regulation of human alveolar macrophage-derived interleukin-1beta and tumor necrosis factor-alpha by iron. J. Lab. Clin. Med. 132 (1998) 497-506
7. Tanji K., Imaizumi T., Matsumiya T., Itaya H., Fujimoto K., Cui X., Toki T., Ito E., Yoshida H., Wakabayashi K., and Satoh K. Desferrioxamine, an iron chelator, upregulates cyclooxygenase-2 expression and prostaglandin production in a human macrophage cell line. Biochim. Biophys. Acta 1530 (2001) 227-235
8. Choi E.Y., Kim E.C., Oh H.M., Kim S., Lee H.J., Cho E.Y., Yoon K.H., Kim E.A., Han W.C., Choi S.C., Hwang J.Y., Park C., Oh B.S., Kim Y., Kimm K.C., Park K.I., Chung H.T., and Jun C.D. Iron chelator triggers inflammatory signals in human intestinal epithelial cells: involvement of p38 and extracellular signal-regulated kinase signaling pathways. J. Immunol. 172 (2004) 7069-7077
9. Nathan C.F., Murray H.W., and Cohn Z.A. The macrophage as an effector cell. N. Engl. J. Med. 303 (1980) 622-626
10. Gazitt Y., Reddy S.V., Alcantara O., Yang J., and Boldt D.H. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate. J. Cell Physiol. 187 (2001) 124-135
11. Scaccabarozzi A., Arosio P., Weiss G., Valenti L., Dongiovanni P., Fracanzani A.L., Mattioli M., Levi S., Fiorelli G., and Fargion S. Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells. Br. J. Haematol. 110 (2000) 978-984
12. Britton R.S., Leicester K.L., and Bacon B.R. Iron toxicity and chelation therapy. Int. J. Hematol. 76 (2002) 219-228
13. Zaman K., Ryu H., Hall D., O'Donovan K., Lin K.I., Miller M.P., Marquis J.C., Baraban J.M., Semenza G.L., and Ratan R.R. Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J. Neurosci. 19 (1999) 9821-9830
14. Yang Y.T., Ju T.C., and Yang D.I. Induction of hypoxia inducible factor-1 attenuates metabolic insults induced by 3-nitropropionic acid in rat C6 glioma cells. J. Neurochem. 93 (2005) 513-525
15. Ivanovic Z., Dello Sbarba P., Trimoreau F., Faucher J.L., and Praloran V. Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent. Transfusion 40 (2000) 1482-1488
16. Desplat V., Faucher J.L., Mahon F.X., Dello Sbarba P., Praloran V., and Ivanovic Z. Hypoxia modifies proliferation and differentiation of CD34(+) CML cells. Stem Cells 20 (2002) 347-354
17. Jiang Y., Xue Z.H., Shen W.Z., Du K.M., Yan H., Yu Y., Peng Z.G., Song M.G., Tong J.H., Chen Z., Huang Y., Lubbert M., and Chen G.Q. Desferrioxamine induces leukemic cell differentiation potentially by hypoxia-inducible factor-1 alpha that augments transcriptional activity of CCAAT/enhancer-binding protein-alpha. Leukemia 19 (2005) 1239-1247
18. Marklund S.L., Westman N.G., Lundgren E., and Roos G. Copper-and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res. 42 (1982) 1955-1961
19. Mietus-Snyder M., Glass C.K., and Pitas R.E. Transcriptional activation of scavenger receptor expression in human smooth muscle cells requires AP-1/c-Jun and C/EBPbeta: both AP-1 binding and JNK activation are induced by phorbol esters and oxidative stress. Arterioscler. Thromb. Vasc. Biol. 18 (1998) 1440-1449
20. Scatena R., Nocca G., Sole P.D., Rumi C., Puggioni P., Remiddi F., Bottoni P., Ficarra S., and Giardina B. Bezafibrate as differentiating factor of human myeloid leukemia cells. Cell Death Differ. 6 (1999) 781-787
21. Kurosawa M., Numazawa S., Tani Y., and Yoshida T. ERK signaling mediates the induction of inflammatory cytokines by bufalin in human monocytic cells. Am. J. Physiol. Cell Physiol. 278 (2000) C500-C508
22. Hara M., Arita M., Yamazaki Z., Hagiwara A., and Saito Y. Antigenic and biochemical characterization of poliovirus type 1 isolates. Microbiol. Immunol. 31 (1987) 327-336
23. Geng Y., Kodama T., and Hansson G.K. Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler. Thromb. 14 (1994) 798-806
24. Krieger M., and Herz J. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63 (1994) 601-637
25. Kim S.J., Hwang S.G., Shin D.Y., Kang S.S., and Chun J.S. p38 kinase regulates nitric oxide-induced apoptosis of articular chondrocytes by accumulating p53 via NFkappa B-dependent transcription and stabilization by serine 15 phosphorylation. J. Biol. Chem. 277 (2002) 33501-33508
26. Krishan A. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66 (1975) 188-193
27. Kim S.H., Johnson V.J., Shin T.Y., and Sharma R.P. Selenium attenuates lipopolysaccharide-induced oxidative stress responses through modulation of p38 MAPK and NF-kappaB signaling pathways. Exp. Biol. Med. (Maywood) 229 (2004) 203-213
28. Ruoslahti E., and Pierschbacher M.D. New perspectives in cell adhesion: RGD and integrins. Science 238 (1987) 491-497
29. Aota S., Nomizu M., and Yamada K.M. The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J. Biol. Chem. 269 (1994) 24756-24761
30. Jordan A., and Reichard P. Ribonucleotide reductases. Annu. Rev. Biochem. 67 (1998) 71-98
31. Schwende H., Fitzke E., Ambs P., and Dieter P. Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3. J. Leukoc. Biol. 59 (1996) 555-561
32. Seger R., and Krebs E.G. The MAPK signaling cascade. Faseb J. 9 (1995) 726-735
33. Dudley D.T., Pang L., Decker S.J., Bridges A.J., and Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA. 92 (1995) 7686-7689
34. Kramer R.M., Roberts E.F., Um S.L., Borsch-Haubold A.G., Watson S.P., Fisher M.J., and Jakubowski J.A. p38 mitogen-activated protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2) in thrombin-stimulated platelets. Evidence that proline-directed phosphorylation is not required for mobilization of arachidonic acid by cPLA2. J. Biol. Chem. 271 (1996) 27723-27729
35. Kumar S., Jiang M.S., Adams J.L., and Lee J.C. Pyridinylimidazole compound SB 203580 inhibits the activity but not the activation of p38 mitogen-activated protein kinase. Biochem. Biophys. Res. Commun. 263 (1999) 825-831
36. Oh H.M., Choi S.C., Lee H.S., Chun C.H., Seo G.S., Choi E.Y., Lee H.J., Lee M.S., Yeom J.J., Choi S.J., Han W.C., Oh J.M., Chung Y.T., Chun J.S., Lee K.M., and Jun C.D. Combined action of extracellular signal-regulated kinase and p38 kinase rescues Molt4 T cells from nitric oxide-induced apoptotic and necrotic cell death. Free Radic. Biol. Med. 37 (2004) 463-479
37. Meister A. modification of glutathione metabolism. Science 220 (1983) 472-477
38. Deneke S.M., and Fanburg B.L. Regulation of cellular glutathione. Am. J. Physiol. 257 (1989) L163-L173
39. Keberle H. The biochemistry of desferrioxamine and its relation to iron metabolism. Ann. N. Y. Acad. Sci. 119 (1964) 758-768
40. Kramer J.L., Baltathakis I., Alcantara O.S., and Boldt D.H. Differentiation of functional dendritic cells and macrophages from human peripheral blood monocyte precursors is dependent on expression of p21 (WAF1/CIP1) and requires iron. Br. J. Haematol. 117 (2002) 727-734
41. Vlahopoulos S., Boldogh I., Casola A., and Brasier A.R. Nuclear factor-kappaB-dependent induction of interleukin-8 gene expression by tumor necrosis factor alpha: evidence for an antioxidant sensitive activating pathway distinct from nuclear translocation. Blood 94 (1999) 1878-1889
42. Harada T., and Mayberg M.R. Inhibition of delayed arterial narrowing by the iron-chelating agent deferoxamine. J. Neurosurg. 77 (1992) 763-767
43. Videla L.A., Villena M.I., Salgado C., Canales P., and Lissi E.A. Antioxidant capacity of desferrioxamine in biological systems. Biochem. Int. 15 (1987) 205-214
44. Ertabak A., Kutluay T., Unlu A., Turkozkan N., Cimen B., and Yaman H. The effect of desferrioxamine on peroxynitrite-induced oxidative damage in erythrocytes. Cell Biochem. Funct. 22 (2004) 149-152